[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study

[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study

Autonomic involvement, including cardiac denervation, may precede the motor symptoms of Parkinson’s disease by several years. L-3,4-dihydroxy-6-[18F] fluoro-phenylalanine is a positron emitter and a true analog of L-dopa, used in clinical practice to assess striatal dopaminergic integrity. The prese...

Full description

Bibliographic Details
Main Author: Jonathan Kuten, Adi Linevitz, Hedva Lerman, Nanette Freedman, Meir Kestenbaum, Tamara Shiner, Nir Giladi, Einat Even-Sapir
Format: Article
Language:English
Published: IMR (Innovative Medical Research) Press Limited 2020-09-01
Series:Journal of Integrative Neuroscience
Subjects:
|parkinson’s disease|positron emission tomography|myocardium|neuroimaging
Online Access:https://jin.imrpress.com/fileup/1757-448X/PDF/1601432747551-43610672.pdf

Internet

https://jin.imrpress.com/fileup/1757-448X/PDF/1601432747551-43610672.pdf

Similar Items